Tom Van Maerken

Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma

Tom Van Maerken, Frank Speleman, Joëlle Vermeulen et al. · Cancer Research · 2006 · 158 citations · Full text

Apoptosis, Cell Death, Pharmacotherapy +20

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

Pieter Mestdagh, Erik Fredlund, Filip Pattyn et al. · Oncogene · 2010 · 146 citations · Full text

Tumor Biology, Glioma, Neuroblastoma Tumours +10

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer

Liesbeth Ferdinande, Christine Decaestecker, Laurine Verset et al. · British Journal of Cancer · 2011 · 144 citations · Full text

Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53

Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman et al. · JNCI Journal of the National Cancer Institute · 2009 · 120 citations

Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma

Seok‐Geun Lee, Hyerin Jeon, Zhao Su et al. · Oncogene · 2009 · 100 citations · Full text

Neuro-oncology, Gene-1 Contributes, Pathology +6